NOW AVAILABLE
- From Polls to Portfolios: A Comprehensive Look at Election Economics
March 20, 2024
Michael Townsend, Managing Director, Legislative and Regulatory Affairs, at Charles Schwab & Co., Inc.
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
ARCHIVE
- Sorting Through Value and Risk in Real Estate Markets
July 26, 2023
Douglas A. Schwartz, Managing Director at J.P. Morgan
Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- Private Equity and Venture Capital
April 27, 2023
Brian Borton, Partner at StepStone
Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- 2023 The Year Ahead
January 17, 2023
Josh Hirt, Senior Economist at Vanguard Investment Strategy Group
Tim Callan, Managing Partner, Callan Capital
- Real Estate & Inflation
July 28, 2022
Karen Sprogis, Managing Director at Blackstone
Tim Callan, Managing Partner, Callan Capital
- Policy and Politics
March 2, 2022
Michael Townsend, Managing Director, Legislative and Regulatory Affairs, at Charles Schwab & Co., Inc.
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- 2022 Market Outlook
February 2, 2022
Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- Fireside Chat
September 21, 2021
Liz Ann Sonders, Managing Director and Chief Investment Strategist at Charles Schwab & Co., Inc.
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- Mid-Year Economic and Market Update
August 12, 2021
David Lebovitz, Global Market Strategist, JP Morgan
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- The Way Forward: 2021 Outlook
January 26, 2021
Mike Arone, Chief Investment Strategist, US SPDR Business
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- Showdown 2020: Trump vs. Biden and the Impact on the Economy
October 21, 2020
Francis Kelly, Deutsche Bank’s Head of Government & Public Affairs
Deepak Puri, Chief Investment Officer for Deutsche Bank Wealth Management Americas
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- COVID and the Impact on Commercial Real Estate
September 24, 2020
Kevin Thorpe, Chief Economist, Head of Global Research, Cushman & Wakefield
Casey Frazier, Founder, Chief Investment Officer, Versus Capital
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- The Current State of COVID and the Future of Healthcare
September 3, 2020
Chris D. Van Gorder, FACHE, President and CEO, Scripps Health
Ghazala Sharieff, M.D., MBA, Chief Medical Officer, Clinical Excellence and Experience, Scripps Health
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- Coronavirus Treatments and Vaccines, a Conversation with the Scripps Research Institute
July 1, 2020
Michael Farzan, Ph.D., Professor and co-chair of the Department of Immunology and Microbiology at Scripps Research
Arnad Chatterjee, Ph.D., Vice President, Medicinal Chemistry, Calibr, Scripps Research
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- The Markets and the Real Economy
May 14, 2020
Michael Arone, Chief Investment Strategist, State Street Global Advisors
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
- 2020 Coronavirus Market Update featuring Jeffrey Kleintop
April 30, 2020
Jeffrey Kleintop, Chief Global Investment Strategist, Charles Schwab
Special Guests: Trevor Callan, Managing Partner, Callan Capital & Tim Callan, Managing Partner, Callan Capital
The information provided is for informational purposes only and should not be considered investment advice. There is a risk of loss from investments in securities, including the risk of loss of principal. The information contained herein reflects Callan Capital’s views as of the date of distribution. Such views are subject to change at any time without notice due to changes in market or economic conditions and may not necessarily come to pass. Callan Capital does not provide tax or legal advice. To the extent that any material herein concerns tax or legal matters, such information is not intended to be solely relied upon nor used for the purpose of making tax and/or legal decisions without first seeking independent advice from a tax and/or legal professional. Callan Capital has obtained the information provided herein from various third-party sources believed to be reliable but such information is not guaranteed. Certain links provided connect to other Web Sites maintained by third parties over whom Callan Capital has no control. Callan Capital makes no representations as to the accuracy or any other aspect of information contained in other Web Sites. Any forward-looking statements or forecasts are based on assumptions and actual results are expected to vary from any such statements or forecasts. No reliance should be placed on any such statements or forecasts when making any investment decision. Callan Capital is not responsible for the consequences of any decisions or actions taken as a result of information provided in this presentation and does not warrant or guarantee the accuracy or completeness of this information. No part of this material may be (i) copied, photocopied, or duplicated in any form, by any means, or (ii) redistributed without the prior written consent of Callan Capital. For detailed information about our services and fees, please read our Form ADV Part 2A, and our Form CRS which can be found at https://www.advisorinfo.sec.gov or you can call us and request a copy at (866) 912-4888.